Real-time index price for S&P 500 Health Care [Sector] (SRHC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER visit. Raja says not ...

As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...

Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be presented at ECO 2025 - covering burden, and the value of treatment and prevention ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

HealthDay News — For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes, according to a study ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...

With the FDA removing semaglutide ... tend to boost patient adherence. Novo Nordisk and Lilly have both announced price cuts for their respective obesity injections, allowing cash-paying patients ...

In the short term, Novo Nordisk’s Ozempic (semaglutide) weekly GLP-1 looks likely to raise the standard of care, particularly as the drug could become available in a patient-friendly daily pill.